Why does this need charitable funding rather than existing profit incentives being sufficient? Is the assumption that non-pandemic use wouldn’t be profitable enough?
EA funding would just speed things up, which I think would be worth the money.
I haven’t read enough to work out why this hasn’t seem more investment yet—a potential reason is that it might be harder to protect intellectual property and profit off these treatments compared to a medication.
Why does this need charitable funding rather than existing profit incentives being sufficient? Is the assumption that non-pandemic use wouldn’t be profitable enough?
EA funding would just speed things up, which I think would be worth the money.
I haven’t read enough to work out why this hasn’t seem more investment yet—a potential reason is that it might be harder to protect intellectual property and profit off these treatments compared to a medication.